These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29470529)

  • 1. Xenopus: An alternative model system for identifying muco-active agents.
    Sim HJ; Kim SH; Myung KJ; Kwon T; Lee HS; Park TJ
    PLoS One; 2018; 13(2):e0193310. PubMed ID: 29470529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airway mucus in pulmonary diseases: Muco-adhesive and muco-penetrating particles to overcome the airway mucus barriers.
    Pangeni R; Meng T; Poudel S; Sharma D; Hutsell H; Ma J; Rubin BK; Longest W; Hindle M; Xu Q
    Int J Pharm; 2023 Mar; 634():122661. PubMed ID: 36736964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways.
    Lai H; Rogers DF
    J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):219-31. PubMed ID: 20695774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the effect of mucus rheology on the muco-ciliary transport.
    Sedaghat MH; Shahmardan MM; Norouzi M; Nazari M; Jayathilake PG
    Math Biosci; 2016 Feb; 272():44-53. PubMed ID: 26656465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of airway mucus hypersecretion.
    Rogers DF; Barnes PJ
    Ann Med; 2006; 38(2):116-25. PubMed ID: 16581697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled gene therapy of preclinical muco-obstructive lung diseases by nanoparticles capable of breaching the airway mucus barrier.
    Kim N; Kwak G; Rodriguez J; Livraghi-Butrico A; Zuo X; Simon V; Han E; Shenoy SK; Pandey N; Mazur M; Birket SE; Kim A; Rowe SM; Boucher R; Hanes J; Suk JS
    Thorax; 2022 Aug; 77(8):812-820. PubMed ID: 34697091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiology of airway mucus secretion and pathophysiology of hypersecretion.
    Rogers DF
    Respir Care; 2007 Sep; 52(9):1134-46; discussion 1146-9. PubMed ID: 17716382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin and MucXS release by small secretory cells depend on Xpod, a SSC specific marker gene.
    Kurrle Y; Kunesch K; Bogusch S; Schweickert A
    Genesis; 2020 Feb; 58(2):e23344. PubMed ID: 31705622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model of mucociliary clearance in cystic fibrosis lungs.
    Kurbatova P; Bessonov N; Volpert V; Tiddens HA; Cornu C; Nony P; Caudri D;
    J Theor Biol; 2015 May; 372():81-8. PubMed ID: 25746843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease.
    Maestrelli P; Saetta M; Mapp CE; Fabbri LM
    Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 2):S76-80. PubMed ID: 11734472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model systems for investigating mucin gene expression in airway diseases.
    Rose MC; Piazza FM; Chen YA; Alimam MZ; Bautista MV; Letwin N; Rajput B
    J Aerosol Med; 2000; 13(3):245-61. PubMed ID: 11066028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravital microscopic optical coherence tomography imaging to assess mucus-mobilizing interventions for muco-obstructive lung disease in mice.
    Pieper M; Schulz-Hildebrandt H; Mall MA; Hüttmann G; König P
    Am J Physiol Lung Cell Mol Physiol; 2020 Mar; 318(3):L518-L524. PubMed ID: 31994896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LPS-induced mucin expression in human sinus mucosa can be attenuated by hCLCA inhibitors.
    Hauber HP; Goldmann T; Vollmer E; Wollenberg B; Hung HL; Levitt RC; Zabel P
    J Endotoxin Res; 2007; 13(2):109-16. PubMed ID: 17621552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel serotonin-secreting cell type regulates ciliary motility in the mucociliary epidermis of Xenopus tadpoles.
    Walentek P; Bogusch S; Thumberger T; Vick P; Dubaissi E; Beyer T; Blum M; Schweickert A
    Development; 2014 Apr; 141(7):1526-33. PubMed ID: 24598162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucus pathophysiology in COPD: differences to asthma, and pharmacotherapy.
    Rogers DF
    Monaldi Arch Chest Dis; 2000 Aug; 55(4):324-32. PubMed ID: 11057087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An optimized protocol for assessment of sputum macrorheology in health and muco-obstructive lung disease.
    Völler M; Addante A; Rulff H; von Lospichl B; Gräber SY; Duerr J; Lauster D; Haag R; Gradzielski M; Mall MA
    Front Physiol; 2022; 13():912049. PubMed ID: 35991170
    [No Abstract]   [Full Text] [Related]  

  • 17. Heparin inhibits mucus hypersecretion in airway epithelial cells.
    Ogawa T; Shimizu S; Tojima I; Kouzaki H; Shimizu T
    Am J Rhinol Allergy; 2011; 25(2):69-74. PubMed ID: 21679503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,8-Cineol Reduces Mucus-Production in a Novel Human Ex Vivo Model of Late Rhinosinusitis.
    Sudhoff H; Klenke C; Greiner JF; Müller J; Brotzmann V; Ebmeyer J; Kaltschmidt B; Kaltschmidt C
    PLoS One; 2015; 10(7):e0133040. PubMed ID: 26207629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucous hypersecretion and relationship to cough.
    Nadel JA
    Pulm Pharmacol Ther; 2013 Oct; 26(5):510-3. PubMed ID: 23434445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor inhibitor AG1478 inhibits mucus hypersecretion in airway epithelium.
    Takezawa K; Ogawa T; Shimizu S; Shimizu T
    Am J Rhinol Allergy; 2016; 30(1):1-6. PubMed ID: 26867523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.